ArticleFrontiers in medicine2026
A novel diagnostic model for HIV-HTN comorbidity: genomic discovery, clinical validation, and mechanistic elucidation.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypertension (HTN) is a frequent comorbidity in people living with Human Immunodeficiency Virus (HIV), yet the shared molecular determinants remain poorly defined. This study aimed to identify diagnostic biomarkers and regulatory networks underlying HIV-HTN comorbidity. Methods: Transcriptomic datasets from HIV (GSE140713) and HTN (GSE236442) cohorts were analyzed to screen differentially expressed genes. Functional enrichment, GSEA, and PPI analyses were performed to uncover shared pathways and hub genes. Immune cell infiltration was evaluated using CIBERSORT. Transcriptional and post-transcriptional regulatory networks were constructed through NetworkAnalyst, miRNet, and starBase. Key genes were validated in peripheral blood samples from healthy individuals, HIV patients, and HIV-HTN patients using qRT-PCR. Results: A total of 109 overlapping genes were identified, converging on cytokine-cytokine receptor interaction, IL-17, and NF-κB pathways. Six hub genes ( Conclusion: This integrative analysis suggests potential molecular signatures and immune-related regulatory axes that may contribute to HIV-HTN comorbidity, providing hypothesis-generating leads for biomarker discovery and mechanistic follow-up studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.